(66 days)
Not Found
No
The device description and performance studies focus on the physical characteristics and biocompatibility of a catheter, with no mention of AI or ML.
No
The device is intended to "assess advancement through the cervical canal and positioning of the uterus" and "facilitate catheter positioning and placement during embryo replacement," which are diagnostic and procedural support functions, not therapeutic.
No
The device is described as assisting with "advancement through the cervical canal and positioning of the uterus" and "facilitates catheter positioning and placement during embryo replacement." This indicates an interventional/procedural use rather than a diagnostic one, as it's used to physically interact with and prepare the anatomical site for another procedure (embryo replacement), rather than to diagnose a condition or derive a medical conclusion.
No
The device description clearly details a physical catheter with specific dimensions, materials (polypropylene), and physical features (graduated markings, Luer Lock Adaptor). There is no mention of software as a component of the device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "assess advancement through the cervical canal and positioning of the uterus." This is a physical assessment of anatomical structures, not a test performed in vitro (outside the body) on biological specimens to diagnose a condition or provide information about a physiological state.
- Device Description: The device is a catheter designed for physical insertion and measurement within the body. It does not involve the analysis of biological samples.
- Lack of IVD Characteristics: There is no mention of reagents, assays, analysis of biological fluids (like blood, urine, etc.), or any other typical components or processes associated with in vitro diagnostics.
The device is a medical device used for a procedural purpose (assessing uterine positioning), not for diagnostic testing of biological samples.
N/A
Intended Use / Indications for Use
The sterile single-use device is intended to assess advancement through the cervical canal and positioning of the uterus.
The sterile single-use device is intended to assess advancement through the cervical canal and positioning of the uterus.
Product codes (comma separated list FDA assigned to the subject device)
MQF
Device Description
The CooperSurgical Trial Transfer catheters are single-use sterile, disposable, flexible catheters with a round smooth distal end. The tip has a blind/closed end. The device has an overall length of either 18cm or 23cm including a polypropylene Luer Lock Adaptor that is affixed at its proximal end. The inner catheter is a clear tube with a 1.8mm outer diameter and a 0.8mm inner catheter is surrounded by an outer sheath with a 2.3mm outer diameter. This inner catheter has a series of graduated markings that are placed 1cm apart at the proximal end to provide reference to the degree of inner catherer insertion to the uters during embryo placement. The distal 0.1cm length of the outer sheath possesses a gradual taper and is shorter than the inner catheter leaving the distal 5cm of the inner catheter exposed. The proximal circumferences of the outer sheath and inner catheter are molded directly into the distal end of the Luer Lock Adaptor. Five black (ink) graduation markings are located on the distal portion of the outer sheath at 1cm increments to indicate the degree of advanced into the cervix. This facilitates catheter positioning and placement during embryo replacement with an assisted reproduction catheter.
The subject devices will be packaged in a flexible pouch composed of Tyvek heat sealed to polyethylene film. The pouch is designed to be peeled open. The pouches will be placed in a carton. Each carton will contain 10 units.
The two versions to be offered are: AR-TT18 (18cm) and AR-TT23 (23cm).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cervical canal, uterus
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The subject device has been subject to biocompatibility testing (for the materials that is equivalent to ISO 10993-1 Biocompatibility requirements. The subject device also complies with ISO 594-1 1986 Conical fittings with a 6% (luer) taper requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Wallace Trial Transfer Catheter K990348
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 884.6110 Assisted reproduction catheters.
(a)
Identification. Assisted reproduction catheters are devices used in in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), or other assisted reproduction procedures to introduce or remove gametes, zygote(s), preembryo(s), and/or embryo(s) into or from the body. This generic type of device may include catheters, cannulae, introducers, dilators, sheaths, stylets, and component parts.(b)
Classification. Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, biocompatibility testing, and clinical testing).
0
510 (k) Summary
DEC 1 3 2002
Date Prepared [21 CFR 807.92(a)(1)|
October 7, 2002
Submitter's Information [21 CFR 807.92(a)(1)]
Joseph M. Azary C/o CooperSurgical, Inc. P.O. Box 2156 Huntington, CT 06484
Azary Technologies has received authorization to submit this 510(k) on behalf of the sponsor CooperSurgical, Inc., 95 Corporate Drive, Trumbull, CT 06611. CooperSurgical, Inc. is an FDA-registered medical device under establishment# 1216677.
Trade Name, Common Name, Classification [21 CFR 807.92(2)(2)]
Trade names are: CooperSurgical Trial Transfer Catheter Common Name: Assisted Reproduction Catheter Classification: Class 11, 21 CFR 884.6110, MQF
Predicate Device [21 CFR 807.92(a)(3)]
- Wallace Trial Transfer Catheter K990348 .
The subject devices have the same indications for use, material composition, sterilization method, and working dimensions as the predicate. A minor difference lies in the fact that the luers of the subject device are slightly larger (both in diameter and length) than the predicate device. The subject device is packaged in a pouch composed of Tyvek and film, whereas the predicate device is packaged in a pouch composed of paper and film. Additional information regarding the predicate device can be found in Annex 4. A chart comparing the subject device to the predicate device can be found in Annex 7.
Description of the Device [21 CFR 807.92(a)(4){
The CooperSurgical Trial Transfer catheters are single-use sterile, disposable, flexible catheters with a round smooth distal end. The tip has a blind/closed end. The device has an overall length of either 18cm or 23cm including a polypropylene Luer Lock Adaptor that is affixed at its proximal end. The inner catheter is a clear tube with a 1.8mm outer diameter and a 0.8mm inner catheter is surrounded by an outer sheath with a 2.3mm outer diameter. This inner catheter has a series of graduated markings that are placed 1cm apart at the proximal end to provide reference to the degree of inner catherer insertion to the uters during embryo placement. The distal 0.1cm length of the outer sheath possesses a gradual taper and is shorter than the inner catheter leaving the distal 5cm of the inner catheter exposed. The proximal circumferences of the outer sheath and inner catheter are molded directly into the distal end of the Luer Lock Adaptor. Five black (ink) graduation markings are located on the distal portion of the outer sheath at 1cm increments to indicate the degree of advanced into the cervix. This facilitates catheter positioning and placement during embryo replacement with an assisted reproduction catheter.
1
FDA 510(k) Premarket Notification CooperSurgical - Trial Transfer Catheter
.
The subject devices will be packaged in a flexible pouch composed of Tyvek heat sealed to polyethylene film. The pouch is designed to be peeled open. The pouches will be placed in a carton. Each carton will contain 10 units.
The two versions to be offered are: AR-TT18 (18cm) and AR-TT23 (23cm).
The subject devices are composed of the following materials:
| Component | Material | Details |
|---|---|---|
| Inner Catheter | Polyurethane | Pellethane 2363-90A R0120 Poly- |
| urethane | ||
| Outer Sheath | Teflon | Fluortek FEP-20 White (aka |
| Neoflon NP-20) with 8-10% Bar- | ||
| ium Sulfate. | ||
| Luers | Polypropylene (with colorants). | Montell Profax 6323 Compounded |
| by Chroma with PMS 240 U Pink. | ||
| Luers | Montell Profax 6323 Natural com- | |
| pounded by Chroma with FDA | ||
| white colorant. | ||
| Tip Protector | Polyethylene | No patient contact |
Intended Use [21 CFR 807.92(a)(5)]
The sterile single-use device is intended to assess advancement through the cervical canal and positioning of the uterus.
Technological Characteristics [21 CFR 807.92(a)(6)]
CooperSurgical, Inc. believes that the subject device is substantially equivalent to the predicate device. The subject device is composed of the same materials, sterilized using the same method, complies with the same standards, has the same indications for use, and is similar dimensionally. The only differences are with the packaging and the outer diameter and length of the Luer.
Performance Data [21 CFR 807.92(b)(1)|
The subject device has been subject to biocompatibility testing (for the materials that is equivalent to ISO 10993-1 Biocompatibility requirements. The subject device also complies with ISO 594-1 1986 Conical fittings with a 6% (luer) taper requirements.
Conclusion [21 CFR 807.92(b)(3)]
We believe the changes are minor and conclude that the subject devices are as safe and effective as the predicate devices.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three overlapping wing shapes, suggesting movement or flight.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 13 2002
CooperSurgical, Inc. % Mr. Joseph M. Azary Azary Technologies, LLC P.O. Box 2156 HUNTINGTON CT 06484
Re: K023384 Trade/Device Name: CooperSurgical, Inc.
Trial Transfer Catheter Regulation Number: 21 CFR 884.6110 Regulation Name: Assisted reproduction catheters Regulatory Class: II Product Code: 85 MQF Dated: December 3, 2002 Received: December 4, 2002
Dear Mr. Azary:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
3
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely vours.
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
FDA 510(k) Premarket Notification CooperSurgical - Trial Transfer Catheter
5 10(k) Number (if known): K023384
Device Name: CooperSurgical, Inc. Trial Transfer Catheter
The sterile single-use device is intended to assess advancement through the cervical canal and positioning of the uterus. .
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH Office of Device Evaluation (ODE)
Dancy C. Broadon
(Division Sign-Off) Division of Reproductive, and Radiological Devices 510(k) Number OR
2023589
Over-The-Counter Use
(Optional Format 1-2-96)
Prescription Use (Per 21 CFR 801.109)